The fallout from the F.D.A.’s rejection of a new treatment for PTSD worries researchers and experts who fear other psychedelic drugs in the pipeline could be jeopardized.
Category: Multidisciplinary Assn for Psychedelic Studies
-
Three MDMA Studies Are Retracted by Scientific Journal
The psychedelic treatment, for PTSD, was rejected last week by government regulators.
-
FDA Panel Rejects Use of MDMA for Treatment of PTSD
An independent group of experts expressed concerns that the data from clinical trials did not outweigh risks for treatment of post-traumatic stress disorder.
-
FDA Panel Weights MDMA Therapy for PTSD
An independent group of experts is meeting Tuesday to consider whether to allow use of this illegal drug, also known as Ecstasy, to treat PTSD.